Explore ›
Finding
Finding
improvement
Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvastatin alone.
| Effect size | Microalbuminuria -8.1%, macroalbuminuria -14.6% |
| Follow-up | 4.7 years |
| Comparator | Placebo added to simvastatin (20-40 mg/day) |
| Effect summary | improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6% |
Connected entities
Interventions
Conditions
Populations
Source
PMC4509601
The ACCORD-Lipid study: implications for treatment of dyslipidemia in Type 2 diabetes mellitus